BN

Balasubramani Nandini Priyanka

Active Director Director DIN 09393574
DIN 09393574 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Balasubramani Nandini Priyanka

Data last updated:

Balasubramani Nandini Priyanka is a Director at Neuroclinical Innovative Solutions Private Limited (since 2021). The company operates in Healthcare.

DIN 09393574
Primary Designation Director
Industry Healthcare
First Appointment 10 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Nov 20212021Active

Board colleagues of Balasubramani Nandini Priyanka

Directorship timeline

Open interactive timeline →
Neuroclinical Innovative Solutions Private Limited
Premium access

Shareholding and investment profile for Balasubramani Nandini Priyanka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balasubramani Nandini Priyanka

Balasubramani Nandini Priyanka currently holds 1 directorship: Neuroclinical Innovative Solutions Private Limited (Director, since 10 Nov 2021).

Balasubramani Nandini Priyanka was first appointed on 10 Nov 2021 as Director at Neuroclinical Innovative Solutions Private Limited.

The current boards of Balasubramani Nandini Priyanka's companies include Balasubramani Aathithya Sidtharthan (Neuroclinical Innovative Solutions Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available